⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACAD News
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
ACAD
Major General Thomas Bouchard, USA (Ret.) Joins Academy Securities’ Advisory Board and Geopolitical Intelligence Group
businesswire.com
ACAD
Americans Carry $1.21 Trillion in Credit Card Debt, with 73% Tied to Essentials and Median Interest Rates at 25.3%
prnewswire.com
ACAD
Shelby Pierson Joins Academy Securities’ Advisory Board and Geopolitical Intelligence Group
businesswire.com
ACAD
The Return of KUKAN: An Oscar-Winning Documentary Legend Released Worldwide
prnewswire.com
ACAD
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
businesswire.com
ACAD
Liberty All-Star® Growth Fund, Inc. November 2025 Monthly Update
businesswire.com
ASG
NVDA
AAPL
MSFT
GOOGL
AMZN
META
NTRA
OLLI
SMTC
ARTV
PSTG
CW
LLY
ACAD
DHR
PLTR
Acadia Pharmaceuticals Announces FDA Approval of DAYBUE ® STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome
businesswire.com
ACAD
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
businesswire.com
ACAD
Acadia Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operating Overview
businesswire.com
ACAD